Raw pharma products import in India has always revolved around China. According to an elite source of import-export data, it has been reported that 80% of raw pharmaceuticals in India come from China. Consequently, more than half of India's healthcare system depends on China for powerful drugs for medicinal uses. However, in 2020, the Government of India validated the Atma Nirbhar Bharat Movement (Self-Reliant Indian Movement). During this movement, the Government requested its largest native pharmaceutical organizations to increase the production of raw pharma products. As a consequence, India could avoid depending on China entirely for drugs. 

This meeting came out as a surprise for the import-export authorities in India. But, during one of these meetings, India decided to produce 38 APIs in-house. In early 2020, cross-border tension between China and India has been challenging to avoid. Not only this, but after the Indian Army confirms China's army authorities about a beginning and unreasonable attack, the Indian Government ended up banning up to 59 Chinese Mobile Apps, including TikTok. 

Behind taking such a crucial step towards the success of the movement, one of the Indian Healthcare authorities mentions that depending on China for Raw Pharma products import in India can soon turn into a threat if not resolved. India's close relationships with the United States has been bothering China for a long time. In 2019, when COVID-19 widespread began, the USA publicly blamed China for triggering a public health war. Although, China has remained silent at the global level since the CoronaVirus rumoured to come from Wuhan's food market. Therefore, the Chinese's Government's silence has been bothering countries and giving them a sign for something bigger and stronger coming their way. Or yet another weapon. 

One of the primary reasons that the Government of India has spoken about why it is cutting down on imports from China is the negative trade balance. According to Cybex, India import data reports only 20 billion USD exports approximately (specific to Pharmaceutical industry). On the other hand, the forecast exports were 22 billion USD. 

It is also noteworthy to mention that India export data reached 20 billion USD in 2020 as it supplied hydroxychloroquine, paracetamol, and 120 other medicinal tablets to different countries in need. Nevertheless, in recent months in 2021, India has faced challenges at a large level due to the scarcity of cylinder-ed oxygen gas for hospitals, ventilators, and others. 

Cybex also notifies that now that the Government of India is embedded on in-house production of raw pharma products, it holds the possibility of thousands of new employment opportunities for its people. 

Are you thinking of kickstarting a pharmaceutical manufacturing business? Cybex Exim Solution helps you make the right decision by diving in foreign trade data (from the 1990s). Subscribe now at www.Cybex.in for more.